Leukemia is a common childhood cancer. With the right medicines and medical care, most children can be cured, but the treatment is complex and long (often lasting over two yrs). Servier teamed up with European Society for Paediatric Oncology to develop POLARIS, a tool that allows parents to follow every step of their child’s treatment on their smartphone or desktop. The treating physician links parents to a secure site where they access the treatment information. The information is “translated” into an easy-to-understand graphic language that makes it easy for parents and even young patients to follow their treatment plan day-by-day. They can also access additional information about leukemia, specific medical procedures, and information to support recovery.
A new era with new expectations
2022-2023 INTEGRATED ANNUAL REPORT
Servier is transforming itself to better meet society’s expectations
The world is changing, and so are the mindsets.
There is a growing interest from patients in digital solutions, aspirations for more equitable access to healthcare, and new priorities and desires from employees. Servier is transforming itself to better meet society’s expectations.
FOCUS
Digital tech as a super power to serve patient needs
Digital technology has become a part of patients’ everyday lives. It offers them greater control of their health and helps establish a more equitable relationship with health care professionals.
THE SERVIER GROUP
Servier in action
OncoAssist revolutionizing oncology
Every day, oncology professionals must make complex decisions while ensuring the best care possible for their patients. Servier has associated with OncoAssist, an application that supports them by providing useful tools and content. Features include the latest news in oncology, information on medications and a tool to check for potential drug interactions.
Elfie, an app helping users to manage their chronic illness
Half of patients living with hypertension do not correctly follow their treatment plan. This led Servier to join up with the Singapore-based start-up Elfie, whose easy-to-use and, free-to-download app encourages therapeutic adherence. It allows users to monitor their blood pressure, reminds them to take their medicine, serves as a digital pill box, and tracks their daily steps and weight. After a successful launch in Vietnam, Brazil, Turkey and Egypt, we aim to deploy the app in 40 countries over the next four years. The app has been expanded and now covers hypertension, diabetes, dyslipidemia and angina.
This one-stop solution to manage several chronic diseases is a valuable asset to patients, as multimorbidity is quite frequent.
FOCUS
Working toward equal access to medicines
Significant progress in medicine has made it possible to treat and control illnesses that would previously have been fatal. Yet, one third of the world’s population cannot access these essential treatments. We consider why, and what can be done.
YOSR, which means “ease” in Arabic, is the name of our patient assistance program. It has been specially designed to help people struggling to pay for their annual treatment after being diagnosed with hypertension, heart failure or colorectal cancer. The program was launched in the United Arab Emirates, Oman and Kuwait, where many patients do not have health insurance or sufficient coverage. Developed in collaboration with an insurance partner and the health ministries of the countries involved, the idea behind YOSR is to make our innovative treatments both accessible and affordable.
THE SERVIER GROUP
Servier in action
Fighting children’s cancer
Through its first iconic CSR project, Servier seeks to contribute to achieving the World Health Organization’s goal to increase the survival rate of children with cancer globally to at least 60% by 2030. The success of the project requires progress in three areas—improving access to existing treatments, investing in R&D, and supporting patients, their friends, and health care professionals.
WHO certification for Swipha
Swipha, our generics subsidiary in Nigeria, obtained prequalification from the WHO for its dispersible zinc sulfate tablet. It is a rigorous process that evaluates the quality, safety and efficacy of medicinal products. Swipha became the first laboratory in sub-Saharan Africa to obtain this approval. Zinc sulfate is used in combination with oral rehydration therapy to treat diarrhoeal disease, which is the second leading cause of death in children under five years old.
FOCUS
A new world of work
A revolution is taking place in the world of work, prompting employees to reassess their priorities and expectations. In order to continue to attract and retain talent, companies must boost their efforts and bolster their value proposition.
At Servier, I’m working on systemic scleroderma, a rare autoimmune diseases that primarily affects middle-aged women, leaving them with an estimated 11 years to live on average. There is currently no treatment to cure the disease. Servier is committed to combating rare diseases. My job is to try to understand how the disease works by analyzing samples from patients. The idea is to assess potentially promising drug candidates to treat systemic scleroderma. What I really like about my job is that it is useful and practical. And most importantly, what we do brings hope to patients!
THE SERVIER GROUP
Servier in action
44
The number of HR labels obtained in 2023, including 22 subsidiaries certified Great Place to Work and 7 certified Top Employer
66 %
of employees feel engaged (up 5% on 2022)
A “MAP” to Servier 2030!
100% of employees took part in the “MAP” initiative, an interactive experience that enabled managers and their teams to understand and talk about the Servier 2030 strategy. This forum for discussion was greatly appreciated, reflecting our employees top priority—being part of a team.
The “She is Servier” program
Servier launched “She is Servier”, an international leadership network made up of both men and women to support the female leaders of today and tomorrow within the Group. The network organizes conferences, mentoring schemes, training sessions and networking events to help women unlock their potential. By 2025, Servier is aiming to grow the proportion of women in top management positions to 40%.